Careers
Contact Us
Healthcare Professionals

About Us
Our Product
Our Science
Investors
Healthcare Professionals
Careers
Contact Us

Home >
Investors >
Press Release

Cormedix Q2 2024 1

August 14, 2024

Company

Management
team
Board
of directors
Scientific Advisory
Board

DefenCath™

About DefenCath™
LOCK-IT-100

RESEARCH
& DEVELOPMENT

Taurolidine
Pipeline
Early
science

Publications

Publications and presentations
In the news

Investors

Press releases
Whistleblower
Hotline
SEC filings
Presentations
and events
Analyst
coverage
Corporate
governance
FAQs

ABOUT CRBSI

Follow us

300 Connell Drive, 4th Floor
Suite 4200 Berkeley Heights, NJ 07922
TEL +1 908-517-9500
FAX +1 908-375-8272

DEFENCATH, CORMEDIX, the CORMEDIX logo and CORMEDIX INC. are registered trademarks of CorMedix Inc.
© 2024 CorMedix Inc. All rights reserved. US-CORP-0017 05/24

Terms of Use
Privacy
Careers
Contact Us

You have clicked on an external link and will be taken offsite.
Would you like to proceed?

CONTINUE